
Tirzepatide 50mgx10vials
Orders before 2:00 PM CT ship the same business day · Batch COA · Shipping
Details
Tirzepatide: 10-Vial Kit for Laboratory Research
Tirzepatide 50 mg x 10 vials is a 10-vial research kit from VendPeptides: Tirzepatide, dual GIP/GLP-1 receptor agonist peptide, supplied for laboratory research. Every lot ships against an independent third-party certificate of analysis matched to the batch number on the vial, and the certificate — not this page — is the source of purity, identity and net-content values for the material you receive.
This page sets out what the listing states, what the published literature says about Tirzepatide, how the material is handled in a laboratory, and how it compares with related compounds in our Metabolic Research Peptides collection. For research purposes only. Not for human consumption.
What Is Tirzepatide?
Tirzepatide is a synthetic 39-residue peptide built on a GIP backbone and engineered to activate both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. A C20 fatty diacid attached through a linker at lysine-20 binds serum albumin, which is the structural basis for the extended half-life reported in the pharmacokinetic literature.
In a research catalogue it is the reference dual incretin agonist: the compound a laboratory reaches for when the question is receptor cross-talk between GIP and GLP-1 signalling rather than GLP-1 activity alone.
Specification at a Glance
| Attribute | Details |
|---|---|
| Product | Tirzepatide 50 mg x 10 vials |
| Compound | Tirzepatide |
| Class | dual GIP/GLP-1 receptor agonist peptide |
| Formats listed | 50 mg per vial, 10 vials |
| Nominal strength (listing) | 50 mg |
| Pack | 10 vials per kit |
| PubChem entry | Tirzepatide — CID 166567236 |
| Molecular formula (PubChem) | C225H348N48O68 |
| Molecular weight (PubChem) | 4813 g/mol |
| Purity | Lot-specific; reported on the batch certificate of analysis (RP-HPLC) |
| Salt form / net content | Not stated on the listing; see the batch documentation |
| Intended use | For research purposes only. Not for human consumption. |
| Certificate of analysis | Batch-matched COA library |
Research Applications of Tirzepatide
The published research on Tirzepatide is summarised below by application area. These are contexts in which the compound appears in the literature, not claims about outcomes; the model, the endpoint and the concentration belong to the researcher's protocol.
Incretin receptor cross-talk
Paired with a GLP-1-selective agonist such as semaglutide and a GIP-selective tool to separate the contribution of each receptor in cell-based cAMP and arrestin assays.
Biased signalling
Used as a reference ligand in studies of GLP-1 receptor bias, internalisation kinetics and beta-cell signalling in culture.
Preclinical metabolic models
Appears throughout the preclinical literature on incretin pharmacology; the models and endpoints belong to the researcher's protocol, not to this page.
How Tirzepatide Works: Mechanism in the Published Literature
Published binding data describe higher affinity at the GIP receptor than at the GLP-1 receptor, with a biased GLP-1 receptor profile that favours cAMP accumulation over beta-arrestin recruitment and internalisation. That imbalance is why tirzepatide behaves differently from a single GLP-1 agonist in receptor-selectivity panels rather than simply being more potent.
Reconstitution and Handling of Tirzepatide
This section describes laboratory handling of a lyophilized research reagent. It is not a dosing instruction, and no quantity for use in any organism is published here or anywhere on this site.
Lipidated peptides such as tirzepatide are more hydrophobic than short sequences and dissolve more slowly. Introduce the solvent against the vial wall, let it stand, and never vortex; aggregation at high concentration is the usual failure mode.
General practice for every lyophilized vial in our range: allow the sealed vial to reach room temperature before opening, so humid air does not condense onto the cake; introduce the solvent slowly against the inner wall rather than onto the powder; let it stand for two to five minutes; swirl, never shake or vortex. Label the vial with compound, concentration, solvent and date. Our reconstitution guide covers the method in full.
Safety, Compliance and Precautions
Research use only
For research purposes only. Not for human consumption. This is a research chemical for in-vitro and laboratory work by qualified researchers. It is not manufactured to the sterility, endotoxin or particulate standards of a finished pharmaceutical, and a high HPLC purity figure says nothing about those. It must not be administered to humans or animals.
No dose is published, anywhere
Concentration and quantity for any experiment are set by the researcher's institutional protocol. This page states the nominal milligrams per vial from the listing and nothing about amounts for use in any organism; our support team will decline to answer such questions.
Laboratory handling
Handle lyophilized powder with gloves and eye protection in a clean area; avoid generating dust. Treat reconstituted solutions as laboratory chemicals: label, refrigerate, aliquot, and dispose of through your institution's chemical-waste route.
Regulatory status
Research chemicals may lawfully be sold for laboratory research in the United States; they are not approved drugs. Some compounds carry additional restrictions in some jurisdictions, and international buyers are the importer of record. See Are research peptides legal?.
Storage and Shelf Life
Sealed and lyophilized: −20 °C for long-term storage, or 2–8 °C for several months, protected from light and moisture. Lyophilized peptides tolerate ambient temperature for the duration of domestic transit. After reconstitution: 2–8 °C, protected from light, aliquoted rather than repeatedly freeze-thawed. The listing does not state a shelf life for this lot; the certificate of analysis does. See the storage guide.
Tirzepatide Compared With Related Research Compounds
These are the compounds most often run alongside Tirzepatide in the same research area. Each is a different molecule with its own listing and certificate; none is a substitute for another, and blends do not let you attribute an effect to one component.
| Product | Class | Formats listed | Typical research context |
|---|---|---|---|
| Semaglutide Single Vials | GLP-1 receptor agonist peptide | 5Mg Vial, 10Mg Vial, 15Mg Vial, 20Mg Vial, 30Mg Vial, 40Mg Vial, 50Mg Vial, 60Mg Vial | GLP-1 receptor pharmacology |
| Retatrutide 10-Vial Bulk Kit RT | GIP/GLP-1/glucagon receptor triple agonist peptide | 5Mg Kit 50Mg, 10Mg Kit 100Mg, 15Mg Kit 150Mg, 20Mg Kit 200Mg, 30Mg Kit 300Mg, 40Mg Kit 400Mg, 50Mg Kit 500Mg, 60Mg Kit 600Mg | Triple-agonist pharmacology |
| Cagrilintide 10-Pack Kits 5/10mg CG10 | long-acting amylin analogue peptide | 5Mg Kit 50Mg, 10Mg Kit 100Mg, 5Mg Vial, 10Mg Vial | Amylin receptor pharmacology |
| Liraglutide 5mg/10mg | GLP-1 receptor agonist peptide | 5Mg Vial, 10Mg Vial, 5Mg Kit 50Mg, 10Mg Kit 100Mg | Acylation and half-life |
Which to choose: Choose Tirzepatide when the protocol calls for this compound specifically. Choose the single vial to qualify a lot before committing to a kit, and the 10-vial kit when the same lot is needed across a series of experiments, because a kit ships from one batch with one certificate.
What a Good Certificate of Analysis Looks Like
Every lot ships against an independent third-party certificate matched to the batch number on the vial. Check four things when it arrives: the batch number on the certificate is the one on your vial; the RP-HPLC trace shows one dominant, symmetrical peak rather than a cluster of satellite peaks; the mass-spectrometry line reports an observed mass consistent with the compound; and the testing laboratory named is not the synthesis partner. Purity is the peak-area percentage of that trace and does not describe net peptide content by mass, which is reported separately where available. Look any batch up in the COA library.
When Not to Use a Lot, and When to Contact Us
Do not use material whose batch number does not resolve to a certificate, whose lyophilisate has collapsed into a sticky or discoloured mass (moisture ingress), or whose reconstituted solution is cloudy or holds visible particulates after standing. Photograph the vial and contact us within seven days of delivery: transit damage, certificate mismatch and out-of-specification material are replaced or refunded in full. See our refund policy.
Frequently Asked Questions
How is tirzepatide different from semaglutide?
Semaglutide is a GLP-1 receptor agonist built on the native GLP-1 sequence. Tirzepatide is built on a GIP backbone and activates both the GIP and GLP-1 receptors. They are different molecules with different receptor profiles, not two strengths of the same thing.
Does the listing state the salt form or counter-ion?
No. The listing states the compound and the nominal milligrams per vial. Salt form, net peptide content and purity are lot-specific values reported on the certificate of analysis for the batch number printed on your vial.
What does 99% purity mean, and where is it stated?
Purity is the peak-area percentage of the target compound in a reverse-phase HPLC chromatogram at UV 214 nm. It is a lot-specific value reported on the certificate of analysis for the batch number on your vial; this page does not assert a purity for your lot, the certificate does.
Is this for human or animal use?
No. For research purposes only. Not for human consumption. It is a laboratory research chemical and is not intended to diagnose, treat, cure or prevent any condition.
How fast do orders ship?
Orders confirmed before 2:00 PM CT Monday to Friday dispatch the same business day with tracking. Lyophilized peptides are stable at ambient temperature in transit; cold-pack is available on request.
Summary
Tirzepatide 50 mg x 10 vials supplies Tirzepatide (dual GIP/GLP-1 receptor agonist peptide) for laboratory research in 10-vial kit. The listing states the compound and the nominal strength; PubChem supplies the registry identity where one resolved; the batch certificate of analysis supplies purity, mass identity and net content for the lot you receive. For research purposes only. Not for human consumption.
Order Tirzepatide 50 mg x 10 vials — batch-matched COA, same-day U.S. dispatch
Related Research Products
- Semaglutide Single Vials — GLP-1 receptor agonist peptide
- Retatrutide 10-Vial Bulk Kit RT — GIP/GLP-1/glucagon receptor triple agonist peptide
- Cagrilintide 10-Pack Kits 5/10mg CG10 — long-acting amylin analogue peptide
- Liraglutide 5mg/10mg — GLP-1 receptor agonist peptide
- Eloralintide (LY3841136) Research Peptide — long-acting amylin receptor agonist peptide
- Metabolic Research Peptides — browse the full research area
Disclaimer: For research purposes only. Not for human consumption. This material is a research chemical supplied for in-vitro and laboratory research by qualified researchers. It is not a drug, food, dietary supplement, cosmetic or medical device, and is not intended to diagnose, treat, cure or prevent any condition. Nothing on this page is a protocol, a dose or advice on use; those decisions belong to the researcher's institutional protocol. The batch certificate of analysis is the controlling document for every lot-specific value.

